C

Corbus Pharmaceuticals Holdings
D

CRBP

7.79000
USD
0.26
(3.45%)
مغلق
حجم التداول
2,497
الربح لكل سهم
-4
العائد الربحي
-
P/E
-2
حجم السوق
95,289,056
أصول ذات صلة
ABBV
ABBV
5.160
(2.67%)
198.440 USD
A
ACAD
0.355
(2.44%)
14.905 USD
ALNY
ALNY
3.98
(1.56%)
259.33 USD
A
AMRN
0.000
(0.00%)
10.990 USD
GILD
GILD
0.420
(0.41%)
103.660 USD
I
INVA
0.070
(0.38%)
18.710 USD
NVS
NVS
3.000
(2.69%)
114.320 USD
Z
ZYME
0.090
(0.70%)
12.950 USD
المزيد
الأخبار المقالات

العنوان: Corbus Pharmaceuticals Holdings

القطاع: Healthcare
الصناعة: Biotechnology
Corbus Pharmaceuticals Holdings Inc is a precision oncology company with a diversified portfolio and is committed to helping people defeat serious illness by bringing scientific approaches to well-understood biological pathways. The company's development pipeline includes; CRB-701, a next-generation antibody-drug conjugate (ADC) that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload, CRB-601, an anti-integrin monoclonal antibody that blocks the activation of TGF expressed on cancer cells, and CRB-913 a second-generation peripherally restricted CB1 receptor inverse agonist designed to treat obesity.